New advanced validation system from Kaye
30 March 2015 | By Amphenol
Amphenol Advanced Sensors’ Kaye products is pleased to launch the new advanced validation System Kaye Validator AVS at Interphex Show, 21-23 April, New York...
List view / Grid view
News
New research reveals significant burden for patients being treated for sight threatening retinal disease
30 March 2015 | By Victoria White
New data show that the intravitreal injection regimens associated with treating retinal disease can have a detrimental effect on patient quality of life....
See the light with Tecan’s Infinite® M200 PRO
30 March 2015 | By kdm communications
Tecan’s Infinite® M200 PRO reader has helped Californian company Sevident to establish rapid, sensitive immunofluorescence and colorimetric assays based on its proprietary NETs technology...
UCB secures multi-million pound funding boost from UK Government
UCB has announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.
Stallergenes announces the approval in Japan of STG320, the first sublingual immunotherapy tablet for the treatment of house dust mite allergy
30 March 2015 | By Victoria White
Stallergenes has announced that its partner, Shionogi & Co., Ltd has received the approval of STG320 from the Japanese health authorities...
CHMP recommends empagliflozin / metformin hydrochloride for approval in the EU for the treatment of Type 2 Diabetes
30 March 2015 | By Victoria White
BI and Lilly announce they have received a positive opinion from CHMP, recommending empagliflozin/metformin hydrochloride for the treatment type 2 diabetes...
LEO Pharma announces regulatory submission of Enstilar for psoriasis in Europe
27 March 2015 | By Victoria White
LEO Pharma has announced it submitted a MAA to 30 European Health Authorities for Enstilar cutaneous foam for the treatment of psoriasis vulgaris...
BioTek receives 2014 Supplier of the Year award from Fisher Scientific
BioTek Instruments, a global leader in microplate instrumentation technology, recently received the '2014 Supplier of the Year' award from Fisher Scientific, part of Thermo Fisher Scientific. The award was presented to BioTek in Phoenix, Arizona at Fisher Scientific’s annual meeting.
Antibiotics pipeline boasts 741 products, but first-in-class development remains low, says GBI Research
27 March 2015 | By Victoria White
While antibiotics boast a vast pipeline, the majority is dominated by generics, as weak financial incentives and high fail rates have discouraged innovation..
Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US
27 March 2015 | By Victoria White
Novo Nordisk has announced that it has decided to resubmit New Drug Applications of Tresiba and Ryzodeg to the FDA within the month.
Sanofi Pasteur announces FDA approval of Quadracel DTaP-IPV vaccine for children aged 4 to 6
26 March 2015 | By Victoria White
Sanofi Pasteur announces the FDA approval of Quadracel for immunisation against diphtheria, tetanus, pertussis and poliomyelitis in children aged 4 to 6...
Germany’s pharmaceutical market value will crawl to $65 billion by 2020, says GlobalData
26 March 2015 | By Victoria White
Germany pharmaceutical market value, valued at $58.6 billion in 2014, will grow modestly to reach an estimated $65 billion by 2020, says GlobalData...
Apceth initiates Phase II clinical trial for pioneering engineered cell therapy to treat gastrointestinal cancer
26 March 2015 | By Victoria White
Apceth has announced the successful completion of the Phase I and initiation of the Phase II with the engineered cell therapy product Agenmestencel-T...
Sepsis-specific treatment market will expand from 2016 and reach $354 million by 2021
26 March 2015 | By Victoria White
Following the first sepsis-specific product launch in 2016, the treatment market will expand to reach $354 million by 2021, says GlobalData...
Emergent BioSolutions receives FDA approval of Anthrasil for use in the treatment of inhalational anthrax
26 March 2015 | By Victoria White
Emergent BioSolutions has announced that the FDA has approved Anthrasil for treatment of inhalational anthrax in combination with antibacterial drugs...
